Primary Device ID | 00850050080190 |
NIH Device Record Key | ba9cb260-ee36-4997-ab4b-5e86de4aff16 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | iLet Bionic Pancreas |
Version Model Number | Insulin Only |
Catalog Number | BB1003 |
Company DUNS | 835742136 |
Company Name | Beta Bionics, Inc. |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | MR Unsafe |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | false |
Serial Number | true |
Manufacturing Date | true |
Expiration Date | false |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx | |
Phone | 855-745-3800 |
xx@xx.xx |
Device Issuing Agency | Device ID |
---|---|
GS1 | 00850050080190 [Primary] |
QJI | Interoperable Automated Glycemic Controller |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2024-11-15 |
Device Publish Date | 2024-11-07 |
00850050080039 | iLet Bionic Pancreas (Government Starter Kit) |
00850050080190 | iLet Bionic Pancreas (Government Starter Kit) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ILET BIONIC PANCREAS 97893020 not registered Live/Pending |
BETA BIONICS, INC. 2023-04-18 |